Takeda director granted 1,800 RSUs and tax award

Takeda Pharmaceutical director Kimura Koichiro received new equity-based compensation tied to Ordinary Shares.

Rhea-AI Filing Summary

Takeda Pharmaceutical director Kimura Koichiro received new equity-based compensation tied to Ordinary Shares. He was granted 1,800 Ordinary Shares on an award basis at a price of $0.00 per share, bringing his directly held Ordinary Shares to 1,800.

He also received 1,937 units of a Tax Obligation Award, each economically equivalent to one Ordinary Share. According to the disclosure, the 1,800-share award represents restricted stock units that vest on June 1, 2029, while the 1,937-unit Tax Obligation Award will convert to a cash payment at vest primarily to cover tax obligations at the then-current market price.

Insider Trade Summary

Grant/Award: 3,737 shares

Grant/Award 2 txns

Insider Kimura Koichiro

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Tax Obligation Award	1,937	$0.00	$0.00
Grant/Award	Ordinary Shares	1,800	$0.00	$0.00

Holdings After Transaction: Tax Obligation Award — 1,937 contracts (Direct); Ordinary Shares — 1,800 shares (Direct)

Footnotes (2)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029.
2. F2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Key Figures

RSU grant size: 1,800 shares RSU grant price: $0.00 per share Shares held after grant: 1,800 shares +3 more

6 metrics

RSU grant size 1,800 shares Ordinary Shares awarded as restricted stock units

RSU grant price $0.00 per share Award of Ordinary Shares as compensation

Shares held after grant 1,800 shares Total non-derivative Ordinary Shares following transaction

Tax Obligation Award units 1,937 units Economically equivalent to Ordinary Shares

Tax Award exercise/expiration date June 1, 2029 Exercise and expiration date for Tax Obligation Award units

RSU vesting date June 1, 2029 Date when RSUs are scheduled to vest

Key Terms

restricted stock units (RSUs), Tax Obligation Award, economic equivalent, Ordinary Shares

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Tax Obligation Award financial

"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest"

economic equivalent financial

"Each Tax Obligation Award is the economic equivalent of one Ordinary Share"

Ordinary Shares financial

"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

What did Takeda (TAK) director Kimura Koichiro receive in this Form 4 filing?

Kimura Koichiro received 1,800 Ordinary Shares as an equity award and 1,937 Tax Obligation Award units. Both were granted at a price of zero, reflecting compensation rather than open-market purchases, and are tied to future vesting conditions and tax coverage mechanisms.

How many Takeda (TAK) shares does Kimura Koichiro hold after the reported transactions?

After the award, Kimura Koichiro directly holds 1,800 Ordinary Shares. These shares come from a grant rather than market purchases and represent his reported non-derivative position following the transaction, according to the Form 4 filing data provided.

When do Kimura Koichiro’s Takeda (TAK) restricted stock units vest?

The restricted stock units granted to Kimura Koichiro vest on June 1, 2029. Each RSU represents a contingent right to receive one Ordinary Share, aligning his compensation with Takeda’s longer-term performance over the period leading up to that vesting date.

What is the Tax Obligation Award reported for Takeda (TAK) director Kimura Koichiro?

The Tax Obligation Award consists of 1,937 units, each economically equivalent to one Ordinary Share. Upon vesting, these units convert into a cash payment primarily to cover tax obligations, using the then-current market price of Takeda’s Ordinary Shares as the valuation basis.

Is the Takeda (TAK) Form 4 transaction a market purchase or sale of shares?

The Form 4 shows compensation-related awards, not market trades. The 1,800 Ordinary Shares and 1,937 Tax Obligation Award units were granted at zero price as equity and tax-related awards, rather than being bought or sold on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kimura Koichiro

(Last) (First) (Middle)

1-1, NIHONBASHI-HONCHO 2-CHROME

CHUO-KU, TOKYO

(Street)

TOKYO 1038668

(City) (State) (Zip)

JAPAN

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/01/2026		A(1)		1,800	A	$0	1,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Tax Obligation Award	(2)	07/01/2026		A		1,937		06/01/2029	06/01/2029	Ordinary Shares	1,937	$0	1,937	D

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029.

2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

	/s/ Samuel Ntonme, by power of attorney, for Koichiro Kimura	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)